Targeting ovarian cancer
Researchers at WEHI and Melbourne University have shed light on why PARP inhibitor drugs work for some ovarian cancer patients and not others.
Filling in the genetic blanks of breast cancer predisposition
A pioneering University of Melbourne study helps show why around 60 per cent of families with multiple breast cancer cases can’t be explained by genetics.
5 discoveries we can thank twins for
35 years of Twins Research Australia at the University of Melbourne have led to insights into how genes and the environment work together to impact our health.
Epigenetics: Asking cancer the right question
The University of Melbourne is leading research into epigenetic treatments for cancer; learning more about the chromatin biology that regulates our genes.
New test to improve blood cancer treatment
A new test that measures the blood cancer DNA in patients' bloodstream is set to replace bone marrow and lymph node biopsies, and offer more effective treatment